# Jeremiah Franklin Shrack

Jeremiah Franklin Shrack writes about pharmacy-benefit contracts and employer health-plan procurement. Their posts explain how contract terms can affect costs and describe tools for reviewing PBM and broker compensation.

- Profile: https://b2binfluencer.marketing/creators/jeremiah-franklin-shrack/
- LinkedIn: https://www.linkedin.com/in/shrack
- Topics: healthcare
- Based on 14 dated posts, latest 2026-10-07

## Summary

Most useful for PBM contract review and pharmacy-benefits procurement audits aimed at self-funded employers and benefits advisory firms.

- Best for: PBM contract review or pharmacy-benefits procurement audit campaigns with a named commercial tool and direct response.
- Not for: Broad or consumer audiences, product-free editorial voice, long-form video, or independently verified savings claims.
- Check first: Confirm current audience data and independent verification for modeled financial figures.

### Takeaways

- Contract language, not fees, decides how much money leaves
- A guarantee protects the PBM’s average, not your spend
- Compare brokers by how they get paid, not by how they pitch

## Main ideas

- **Contract language, not fees, decides how much money leaves**: The most expensive contract isn’t necessarily the one with the highest fees; it’s the one whose provisions allow the most value to be extracted. Spread pricing, rebate reclassification, and specialty margins are described as invisible taxes on EBITDA. Even “100% of rebates” loses meaning when the PBM controls what qualifies as a rebate. An audit right without data access is “governance theater.” The framing: this is not necessarily fraud, but architecture. The contract’s information advantage becomes the employer’s financial disadvantage, so the task is to trace, test, and quantify provisions rather than renegotiate a feeling.
- **A guarantee protects the PBM’s average, not your spend**: A brand-effective-rate guarantee promises an average on a denominator the PBM defines. The PBM can overcharge the sickest members and undercharge cheap, high-volume scripts and still pass to the decimal. The exclusions are the product: strike specialty drugs, compounds, and authorized generics, and the guarantee covers a shrinking slice. The true-up runs one way: if the PBM misses the number, it pays; if it beats it, it keeps the difference. Meanwhile, the employer’s money floats for about twelve months. AWP is a benchmark, not a price. Because the terms are disclosed in the contract, Shrack calls this worse than fraud in effect: the employer is measured against a rubric written by the party being graded.
- **Compare brokers by how they get paid, not by how they pitch**: Polished finalist decks and identical promises can hide differences that compensation data exposes. The buyer’s move is to check each candidate’s actual pay and grade the pharmacy deal behind each pitch, turning a sales meeting into an audit. A related contrast pits personal responsiveness against institutional familiarity: a fifteen-year local broker who takes the 9 p.m. call when an HR director’s family lands in the emergency room, versus a national incumbent whose advantages are a logo the CFO knows from airports, a stewardship report thick enough to prop a door, and a relationship two renewals deep.
- **Intervene before the RFP, and carry replacement language**: The strongest negotiation position begins before the RFP, with provision-level evidence and substitute contract clauses rather than a complaint. Finding leakage isn’t the competitive advantage; converting evidence into executable contract language is. Speed and cost matter because a fast screen can change a live renewal conversation.
- **Procurement is a promise, and the breach is invisible**: A benefits plan is a promise the employer makes to the people who build the company: to spend the money as carefully as if it were the employees’ own. Each month a cheaper, equivalent therapy sits behind a contractual wall, that promise is broken in small, invisible installments. The same fiduciary logic appears in the leakage argument: leadership cannot manage what it cannot trace, test, and quantify. The question is whether it would still approve the status quo if it knew how much capital the contract could divert.
- **Tension: the promise argument sometimes stands without the numbers**: Shrack’s most quoted posts pair a claim with a mechanism and a figure, but the moral-framing post does neither. It argues the ethics of procurement directly and points readers to a website, without dissecting a contract term or attaching a dollar amount. The fiduciary argument stands on its own, not only as a conclusion drawn from arithmetic.

## Work to read

- [The $65.1 Million Leakage Model: PBM Contracts as Capital Allocation](https://www.linkedin.com/posts/activity-7498765870975086593-uPbM)
- [BER Guarantees Guarantee an Average, Not a Floor](https://www.linkedin.com/posts/activity-7508609773584703488-CDYu)
- [How a CFO Turned Broker Finalists into an Audit](https://www.linkedin.com/posts/activity-7513595415246761985-m0F9)
- [Local Broker vs National Incumbent: What the Stewardship Report Does Not Show](https://www.linkedin.com/posts/activity-7513507382442807296-LOxh)
- [Procurement Has a Moral Dimension](https://www.linkedin.com/posts/activity-7511738412744339457-EJ96)

## Brand relationships

- **SiriusB.Ai** (disclosed_partnership)
- **PBM Contract Clarity** (disclosed_partnership)
- **Broker Compensation Study** (disclosed_partnership)
- **Kincaid RMC** (disclosed_partnership)

## Partnerships

The posts present paid pharmacy-benefit contract review products for self-funded employers or advisory firms—not sponsored-content or brand-partnership formats: PBM Contract Clarity, PBM Contract Clarity 360, and the Broker Compensation Study. For more information, contact jer@kincaidrmc.com, text 219.256.3331, or visit SiriusB.Ai. For a brand partnership, ask whether sponsored-content options are available and request the sponsor policy.

## Alternatives

- Mark Coulson (MCIPS): Choose Mark Coulson when the campaign is about procurement transparency and savings discipline outside pharmacy benefits, especially when the buyer wants to challenge a benchmarking platform, stress-test a rebate arrangement, or show that an experienced negotiator can beat a tool's recommended target. Two posts make that case directly: one describes an online benchmarking platform that advised a 15% saving while an experienced procurement specialist delivered 44%; the other tests six media agencies on whether they return every rebate, bonus, and discount. That makes Mark Coulson a fit for a broader procurement or marketing-spend audit campaign where the buyer must decide whether to trust the benchmark or the negotiator.
- Michael Taylor: Choose Michael Taylor when the campaign focuses on contract compliance and recovery across a large supplier base, including centralized contract repositories, obligation tracking, invoice-to-contract reconciliation, rebate and payment-term reviews, or AI-assisted contract review. The posts suit a finance, procurement, or healthcare supply-chain buyer looking to find money after invoices drift from agreed terms. One lays out six contract-compliance practices; the other describes thematic reviews and a case where a national retailer ran 900+ supplier agreements through contract-analysis software and unlocked $22 million in working capital plus $2.8 million in interest savings. That fits a campaign promising to check what was agreed against what was actually paid.
- Nancy Taylor: Choose Nancy Taylor when the campaign targets small and mid-size employers, benefits brokers, or HR and finance teams around payroll-tax savings and benefits-payroll integration—not PBM contract review. The posts position Nancy Taylor as a layer that works alongside a benefits broker, focuses on FICA liability and Section 125, and cites employer savings of $50,000+ in year one. That fits a campaign where the buyer is deciding whether to review how benefits connect to payroll, with a benefits-payroll integration review as the offer.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/